Efficacy and safety of baricitinib in Japanese patients with rheumatoid arthritis: Subgroup analyses of four multinational phase 3 randomized trials.
about
Efficacy and safety of baricitinib in Japanese patients with rheumatoid arthritis: Subgroup analyses of four multinational phase 3 randomized trials.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Efficacy and safety of baricit ...... nal phase 3 randomized trials.
@en
Efficacy and safety of baricit ...... nal phase 3 randomized trials.
@nl
type
label
Efficacy and safety of baricit ...... nal phase 3 randomized trials.
@en
Efficacy and safety of baricit ...... nal phase 3 randomized trials.
@nl
prefLabel
Efficacy and safety of baricit ...... nal phase 3 randomized trials.
@en
Efficacy and safety of baricit ...... nal phase 3 randomized trials.
@nl
P2093
P2860
P1433
P1476
Efficacy and safety of baricit ...... nal phase 3 randomized trials.
@en
P2093
Koichi Amano
Masayoshi Harigai
Naotsugu Akashi
Osamu Kawaguchi
Taeko Ishii
Tatsuya Atsumi
Terence P Rooney
Yoshiya Tanaka
P2860
P304
P356
10.1080/14397595.2017.1392057
P577
2017-11-14T00:00:00Z